Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 28 X 5 mg |
|
2389 | 15391 |
|
Film Coated Tablets 56 X 7.5 mg |
|
2393 | 15448 |
|
Film Coated Tablets 28 X 10 mg |
|
2396 | 15449 |
Related information
Dosage
See prescribing information for full details.
Indications
Acute and maintenance treatment of schizophrenia.For the management of the manifestations of psychotic disorders. For short-term treatment of acute manic episodes associated with Bipolar I disorder.Prevention of recurrence in bipolar disorder: In patients whose manic episode has responded to olanzapine treatment, for the prevention of recurrence in patients with bipolar disorder.Combination therapy in Bipolar I disorder: The combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I disorder.
Contra-Indications
Known hypersensitivity to olanzapine or to any other ingredient of the product. Patients with known risk of narrow-angle glaucoma. Lactation. Patients suffering from dementia-related psychoses.
